Genetic Modifiers of ABCA1 Activity Interact with APOE Isoforms to Mediate Alzheimer's Disease Risk
Andrés Peña-Tauber1, Ricardo Hernández Arriaza2, Dylan Reil3
1Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA.
Annals of Neurology
|August 4, 2026
Summary
Genetic variants in ATP-binding cassette transporter A1 (ABCA1) modify Alzheimer's disease (AD) risk by interacting with apolipoprotein E (APOE) isoforms. These interactions influence lipid metabolism and disease susceptibility.
Area of Science:
- Neurogenetics
- Molecular Biology
- Biochemistry
Background:
- ATP-binding cassette transporter A1 (ABCA1) plays a crucial role in lipid metabolism, particularly in binding and lipidating apolipoprotein E (ApoE).
- ABCA1 is implicated in Alzheimer's disease (AD) pathogenesis, but the precise mechanisms and interactions with genetic factors remain unclear.
- APOE isoforms (ε2, ε3, ε4) are significant genetic risk factors for AD, influencing disease onset and progression.
Purpose of the Study:
- To investigate whether genetic variants affecting ABCA1 function interact with APOE isoforms to modify AD risk.
- To explore the functional impact of specific ABCA1 variants on AD risk and lipid metabolism.
- To elucidate potential pathogenic mechanisms underlying ABCA1-mediated AD risk modification.
Main Methods:
- Analysis of large-scale genetic datasets (ADSP, UK Biobank, Alzheimer Disease European Sequencing consortium) to assess ABCA1 variant effects on AD risk within APOE genotype subgroups.
- Statistical testing for interactions between ABCA1 variants and APOE ε2/ε4 alleles.
- Construction of a predicted ABCA1 activity score based on high-density lipoprotein (HDL)-associated variants.
- In vitro cell-based assays to examine the cellular effects of specific ABCA1 missense variants.
Main Results:
- Damaging ABCA1 variants showed differential AD risk effects across APOE genotype groups, with significant interactions observed with APOE ε2 and ε4.
- Predicted ABCA1 activity was associated with reduced AD risk and interacted with APOE ε4.
- Specific ABCA1 missense variants (N1800H, E1172D) were strongly linked to plasma HDL levels and interacted with APOE in modulating AD risk.
- Cellular assays indicated that the ABCA1-N1800H variant may cause plasma membrane localization defects due to misfolding.
Conclusions:
- Genetic variations influencing ABCA1 activity interact with APOE isoforms to modulate an individual's risk of developing Alzheimer's disease.
- These findings highlight the complex interplay between ABCA1, APOE, and lipid metabolism in AD pathogenesis.
- Targeting ABCA1 function or its interaction with APOE may offer novel therapeutic strategies for AD prevention or treatment.
Related Concept Videos
01:16Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:28Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...